Search Medical Centers

Grupo Hospitalario Quirónsalud

Location

Madrid, Spain

Dr. Josep Tabernero

Dr. Josep Tabernero

Hospital Quirónsalud Barcelona. Head of the Gastrointestinal and Endocrine Cancers Unit, Instituto Oncológico Baselga
at Grupo Hospitalario Quirónsalud
Speciality Head of the Gastrointestinal and Endocrine Cancers Unit, Instituto
Oncológico Baselga
Languages English, Spanish, Catalan
About Medical specialisation: medical oncology.
Area of special training: GI and endocrine tumors.
Membership in International scientific associations:
- ESMO – European Society for Medical Oncology. President elect, 2018-2019.
- ASCO – American Society of Medical Oncology.
- AACR – American Association for Cancer Research.
- ECCO – European Cancer Organization.
- EORTC – European Organization for Research and Treatment of Cancer.

No. of publications in International journals. Over 250 publications in journals, including: the Lancet, the New England Journal of Medicine, the Annals of Oncology, the Journal Clinical Oncology, the Oncologist, Cancer Chemotherapy Pharmacology, Nature, etc. Dynamic Molecular Analysis and Clinical Correlates of Tumor Evolution Within a Phase 2 Trial of Panitumumab-Based Therapy in Metastatic Colorectal Cancer. Siena S, Sartore-Bianchi A, Garcia-Carbonero R, Karthaus M, Smith D, Tabernero J, Van Cutsem E, Guan X, Boedigheimer M, Ang A, Twomey B, Bach BA, Jung AS, Bardelli A. Ann Oncol. 2017 Sep 4. doi: 10.1093/annonc/mdx504 Cancer: A precision approach to tumour treatment. Dienstmann R, Tabernero J. Nature. 2017 Aug 3;548(7665):40-41. doi: 10.1038/nature23101.

He has participated in the clinical trials that led to the development medications, including: panitumumab, cetuximab, aflibercept, regorafenib and ramucirumab. Tas102

Copyright © 2008 - 2024 Health-Tourism.com, All Rights Reserved